VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
MASS908 Devices Inc.
$8.85$335M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

MASS logo908 Devices Inc.(MASS)Earnings, Financials & Key Ratios

MASS•NASDAQ
16.4× P/E·Price updated Jun 19, 2026
SectorHealthcareIndustryMedical DevicesSub-IndustryDevice suppliers, distribution, and services
About908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.Show more
  • Revenue$56M-5.8%
  • EBITDA-$20M+72.6%
  • Net Income-$37M+49.3%
  • EPS (Diluted)0.54+125.5%
  • Gross Margin47.68%-5.0%
  • EBITDA Margin-35.08%+71.0%
  • Operating Margin-43.03%+66.6%
  • Net Margin-65.2%+46.2%
  • ROE-28.37%+45.0%

MASS Key Insights

908 Devices Inc. (MASS) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Momentum leader: RS Rating 81 (top 19%)
  • ✓Strong 5Y sales CAGR of 15.9%

✗Weaknesses

  • ✗Profits declining 23.4% over 5 years
  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Shares diluted 14.2% in last year
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when MASS posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

MASS Price & Volume

908 Devices Inc. (MASS) stock price & volume — 10-year historical chart

Loading chart...

MASS Growth Metrics

908 Devices Inc. (MASS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years15.88%
3 Years6.25%
TTM2.16%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-102.95%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-81.82%

Return on Capital

10 Years-23.83%
5 Years-22.46%
3 Years-28.86%
Last Year-16.66%

MASS Recent Earnings

908 Devices Inc. (MASS) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 9/12 qtrs (75%)
Q2 2026Latest
May 6, 2026
Metric
Actual
Est
EPS
$0.22-46.7%
$0.15
Rev
$13M+1.7%
$13M
Q2 2026
Mar 3, 2026
Metric
Actual
Est
EPS
$0.05+16.7%
$0.06
Rev
$17M+9.7%
$16M
Q4 2025
Nov 10, 2025
Metric
Actual
Est
EPS
$0.15-30.4%
$0.12
Rev
$14M+3.6%
$14M
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.18-12.5%
$0.16
Rev
$13M-4.0%
$14M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 6, 2026
$0.22vs $0.15-46.7%
$13Mvs $13M+1.7%
Q2 2026Mar 3, 2026
$0.05vs $0.06+16.7%
$17Mvs $16M+9.7%
Q4 2025Nov 10, 2025
$0.15vs $0.12-30.4%
$14Mvs $14M+3.6%
Q3 2025Aug 5, 2025
$0.18vs $0.16-12.5%
$13Mvs $14M-4.0%
Based on last 12 quarters of dataView full earnings history →

MASS Peer Comparison

908 Devices Inc. (MASS) competitors in Device suppliers, distribution, and services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
MASI logoMASIMasimo CorporationDirect Competitor9.42B179.95-64.27-27.1%4.9%9.08%0.78
WAT logoWATWaters CorporationProduct Competitor23.17B355.4433.036.99%11.91%8.04%0.55
A logoAAgilent Technologies, Inc.Product Competitor35.89B127.0627.806.73%19.55%20.84%0.50
TMO logoTMOThermo Fisher Scientific Inc.Product Competitor172.66B464.6126.193.91%15.18%13.23%0.76
BRKR logoBRKRBruker CorporationProduct Competitor8.71B57.23-381.532.08%-0.34%-0.5%0.81
LECO logoLECOLincoln Electric Holdings, Inc.Product Competitor15.09B275.2329.535.54%12.39%37.29%0.88
DHR logoDHRDanaher CorporationSupply Chain125.4B177.1735.152.9%14.89%7.06%0.35
RGEN logoRGENRepligen CorporationSupply Chain7.45B132.02153.5116.36%6.73%2.46%0.33

Compare MASS vs Peers

908 Devices Inc. (MASS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs MASI

Most directly comparable listed peer for MASS.

Scale Benchmark

vs TMO

Larger-name benchmark to compare MASS against a more recognizable public peer.

Peer Set

Compare Top 5

vs MASI, WAT, A, TMO

MASS Income Statement

908 Devices Inc. (MASS) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
22.05M17.97M26.89M42.21M46.85M50.23M59.63M56.2M57.8M
Revenue Growth %
--18.51%49.64%56.93%11.01%7.21%18.72%-5.76%2.16%
Cost of Goods Sold
9.66M9.83M11.97M18.97M20.83M24.91M29.71M29.4M29.48M
COGS % of Revenue
43.81%54.69%44.51%44.95%44.46%49.59%49.82%52.32%-
Gross Profit
12.39M▲ 0%
8.14M▼ 34.3%
14.92M▲ 83.3%
23.23M▲ 55.7%
26.02M▲ 12.0%
25.32M▼ 2.7%
29.93M▲ 18.2%
26.8M▼ 10.5%
28.32M▲ 0%
Gross Margin %
56.19%45.31%55.49%55.05%55.54%50.41%50.18%47.68%49%
Gross Profit Growth %
--34.29%83.26%55.69%12.01%-2.69%18.18%-10.45%-
Operating Expenses
18.83M20.29M20.74M45.3M61.41M68.08M106.64M50.98M58.67M
OpEx % of Revenue
85.39%112.88%77.11%107.34%131.06%135.54%178.84%90.71%-
Selling, General & Admin
9.3M0032.23M43.88M0037.18M27.57M
SG&A % of Revenue
42.19%--76.38%93.65%--66.15%-
Research & Development
9.53M8.99M8.23M13.07M17.53M21.9M25.5M13.8M13.97M
R&D % of Revenue
43.2%50.04%30.62%30.96%37.41%43.61%42.75%24.56%-
Other Operating Expenses
50K11.29M12.5M0046.18M81.15M01000K
Operating Income
-6.44M▲ 0%
-12.14M▼ 88.6%
-5.82M▲ 52.1%
-22.07M▼ 279.5%
-35.38M▼ 60.3%
-42.76M▼ 20.8%
-76.72M▼ 79.4%
-24.18M▲ 68.5%
-30.35M▲ 0%
Operating Margin %
-29.2%-67.57%-21.62%-52.29%-75.52%-85.13%-128.65%-43.03%-52.5%
Operating Income Growth %
--88.6%52.12%-279.52%-60.32%-20.85%-79.42%68.48%-
EBITDA
-5.54M-11.24M-4.98M-21.14M-33.77M-40.37M-72.04M-19.71M-26.03M
EBITDA Margin %
-25.13%-62.56%-18.53%-50.1%-72.07%-80.38%-120.8%-35.08%-45.03%
EBITDA Growth %
--102.85%55.67%-324.24%-59.7%-19.56%-78.42%72.63%56.38%
D&A (Non-Cash Add-back)
896K900K831K925K1.61M2.38M4.68M4.46M4.32M
EBIT
-6.39M-12.14M-5.82M-21.68M-33.43M-42.65M-48.56M-24.18M-23.55M
Net Interest Income
-1.15M-1.53M-976K62K1.9M6.28M4.49M4.14M4.25M
Interest Income
000548K2.03M6.48M4.49M4.14M4.25M
Interest Expense
1.15M1.53M976K486K129K201K000
Other Income/Expense
-1.1M-1.23M-7M-100K1.82M6.15M4.23M-9.16M-5.01M
Pretax Income
-7.54M▲ 0%
-13.37M▼ 77.5%
-12.82M▲ 4.1%
-22.17M▼ 72.9%
-33.56M▼ 51.4%
-36.61M▼ 9.1%
-72.49M▼ 98.0%
-33.34M▲ 54.0%
-35.36M▲ 0%
Pretax Margin %
-34.17%-74.41%-47.66%-52.53%-71.64%-72.89%-121.56%-59.33%-61.17%
Income Tax
50K0000-211K-282K-66K-66K
Effective Tax Rate %
-0.66%0%0%0%0%0.58%0.39%0.2%0.19%
Net Income
-7.54M▲ 0%
-13.37M▼ 77.5%
-12.82M▲ 4.1%
-22.17M▼ 72.9%
-33.56M▼ 51.4%
-36.4M▼ 8.4%
-72.21M▼ 98.4%
-36.64M▲ 49.3%
-35.89M▲ 0%
Net Margin %
-34.17%-74.41%-47.66%-52.53%-71.64%-72.47%-121.09%-65.2%-62.1%
Net Income Growth %
--77.45%4.14%-72.94%-51.4%-8.45%-98.37%49.26%-102.95%
Net Income (Continuing)
-7.54M-13.37M-12.82M-22.17M-33.56M-36.4M-72.21M-33.28M-35.29M
Discontinued Operations
0000000-3.36M-602K
Minority Interest
000000000
EPS (Diluted)
-0.93▲ 0%
-2.02▼ 117.2%
-2.35▼ 16.3%
-0.79▲ 66.4%
-1.07▼ 35.4%
-1.13▼ 5.6%
-2.12▼ 87.6%
0.54▲ 125.5%
-0.97▲ 0%
EPS Growth %
--117.2%-16.34%66.38%-35.44%-5.61%-87.61%125.47%-81.82%
EPS (Basic)
-0.93-2.02-2.35-0.79-1.07-1.13-2.120.54-
Diluted Shares Outstanding
8.12M7.53M5.49M27.96M31.49M32.24M34.08M38.92M36.82M
Basic Shares Outstanding
8.12M7.53M5.49M27.96M31.49M32.21M34.08M36.22M36.82M
Dividend Payout Ratio
---------

MASS Balance Sheet

908 Devices Inc. (MASS) balance sheet — assets, liabilities & shareholders' equity

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
17.2M28.58M170.97M252.89M215.63M173.79M103.06M144.56M142.01M
Cash & Short-Term Investments
7.07M17.91M159.23M224.07M188.42M145.68M69.6M112.97M111.74M
Cash Only
7.07M17.91M159.23M224.07M188.42M121.04M44.03M112.97M67.56M
Short-Term Investments
0000024.64M25.57M044.18M
Accounts Receivable
6.34M5.08M6.83M16.57M10.03M8.99M12.63M11.33M9.87M
Days Sales Outstanding
104.86103.1592.63143.3478.1665.3277.2973.5760.62
Inventory
3.52M5.24M4.57M7.92M12.51M14.94M16.17M12.99M13.24M
Days Inventory Outstanding
133.1194.48139.28152.33219.27218.91198.72161.27176.49
Other Current Assets
00060K4.66M4.18M4.66M7.27M7.17M
Total Non-Current Assets
10.54M9.08M7.86M8.01M26.96M29.19M56.42M45.51M44.68M
Property, Plant & Equipment
10.01M8.57M7.14M6.79M7.04M9.57M10.33M8.63M8.35M
Fixed Asset Turnover
2.20x2.10x3.77x6.22x6.66x5.25x5.77x6.51x7.41x
Goodwill
000010.05M10.37M000
Intangible Assets
00008.49M7.86M45.26M36.41M35.68M
Long-Term Investments
00000171K000
Other Non-Current Assets
531K511K723K1.23M1.38M1.22M829K471K656K
Total Assets
27.75M▲ 0%
37.66M▲ 35.7%
178.83M▲ 374.8%
260.91M▲ 45.9%
242.59M▼ 7.0%
202.98M▼ 16.3%
159.48M▼ 21.4%
190.07M▲ 19.2%
186.69M▲ 0%
Asset Turnover
0.79x0.48x0.15x0.16x0.19x0.25x0.37x0.30x0.30x
Asset Growth %
-35.73%374.82%45.9%-7.02%-16.33%-21.43%19.18%13.31%
Total Current Liabilities
4.76M6.05M10.83M14.84M19.23M22.55M25.15M34.06M39.66M
Accounts Payable
645K577K1M1.37M1.4M1.19M2.06M8.42M2.42M
Days Payables Outstanding
24.3721.4330.6126.3824.4817.4525.35104.5829.09
Short-Term Debt
00500K002.02M1.86M16.71M700K
Deferred Revenue (Current)
951K1.49M3.1M07.51M10.63M12.13M8.93M36.34M
Other Current Liabilities
1.82M1.02M2.07M6.75M3.94M2.72M9.1M027.07M
Current Ratio
3.61x4.72x15.78x17.05x11.22x7.71x4.10x4.24x3.58x
Quick Ratio
2.87x3.86x15.36x16.51x10.56x7.04x3.45x3.86x3.25x
Cash Conversion Cycle
213.6276.2201.3269.29272.95266.78250.66130.26208.02
Total Non-Current Liabilities
73.17M94.78M28.95M31.47M32.76M14.94M19.73M12.31M12.86M
Long-Term Debt
9.65M14.77M14.33M15M15M0003.77M
Capital Lease Obligations
7.97M6.94M5.84M4.51M3.04M3.93M4.74M011.82M
Deferred Tax Liabilities
-8.11M0002.67M2.44M2.03M00
Other Non-Current Liabilities
55.18M72.5M194K11.96M555K02.28M3.98M9.1M
Total Liabilities
77.92M100.83M39.79M46.3M51.99M37.49M44.88M46.37M52.52M
Total Debt
17.93M22.79M21.86M20.85M19.51M5.95M6.61M16.71M4.47M
Net Debt
10.86M4.88M-137.37M-203.22M-168.91M-115.1M-37.42M-96.26M-63.1M
Debt / Equity
--0.16x0.10x0.10x0.04x0.06x0.12x0.03x
Debt / EBITDA
---------0.17x
Net Debt / EBITDA
--------2.42x
Interest Coverage
-5.57x-7.94x-5.96x-44.62x-259.18x-212.19x---
Total Equity
-50.18M▲ 0%
-63.17M▼ 25.9%
139.04M▲ 320.1%
214.6M▲ 54.3%
190.6M▼ 11.2%
165.49M▼ 13.2%
114.59M▼ 30.8%
143.7M▲ 25.4%
134.17M▲ 0%
Equity Growth %
--25.89%320.11%54.35%-11.19%-13.17%-30.76%25.4%8.75%
Book Value per Share
-6.18-8.3925.357.686.055.133.363.693.64
Total Shareholders' Equity
-50.18M-63.17M139.04M214.6M190.6M165.49M114.59M143.7M134.17M
Common Stock
5K5K27K31K32K33K35K36K37K
Retained Earnings
-52.28M-65.65M-78.47M-100.64M-134.2M-170.6M-242.81M-223.32M-235.27M
Treasury Stock
000000000
Accumulated OCI
-2.46M000798K1.36M1.15M54K2K
Minority Interest
000000000

MASS Cash Flow Statement

908 Devices Inc. (MASS) cash flow — operating, investing & free cash flow history

MetricDec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
-8.9M-11M4.13M-29.08M-20.93M-25.06M-30.25M-23.69M-7.58M
Operating CF Margin %
-40.35%-61.23%15.36%-68.9%-44.67%-49.89%-50.72%-42.15%-
Operating CF Growth %
--23.67%137.54%-803.99%28.03%-19.73%-20.7%21.68%346.69%
Net Income
-7.54M-13.37M-12.82M-22.17M-33.56M-36.4M-72.21M19.49M-35.89M
Depreciation & Amortization
896K900K831K925K1.61M2.38M4.68M3.83M4.31M
Stock-Based Compensation
217K267K525K2.5M7.21M9.79M11.76M9.85M2.77M
Deferred Taxes
444K000-129K-305K-283K010K
Other Non-Cash Items
208K460K5.55M2.09M584K1.05M28.34M-41.55M24.96M
Working Capital Changes
-3.13M742K10.04M-12.44M3.36M-1.57M-2.54M-15.3M-4.04M
Change in Receivables
2.53M1.26M-1.82M-11.28M5.93M680K-2.93M220K-2.87M
Change in Inventory
-989K-1.86M223K-4.48M-5.47M-3.9M-1.66M-3.73M-2.15M
Change in Payables
-2.95M002.75M000-5.93M964K
Cash from Investing
-1.17M-392K-9K-737K-15.81M-26.4M-46.32M50.75M-1.56M
Capital Expenditures
-727K-392K-9K-737K-2.04M-2.04M-602K-955K-836K
CapEx % of Revenue
3.3%2.18%0.03%1.75%4.36%4.07%1.01%1.7%1.45%
Acquisitions
0000-13.76M0-44.78M-2M-2.01M
Investments
---------
Other Investing
-440K00000069.91M0
Cash from Financing
3.99M22.24M137.19M94.72M1.18M-15.94M-376K-697K-2.56M
Debt Issued (Net)
05M0-39K0-15M000
Equity Issued (Net)
3.92M17.32M139.03M852K1.55M936K1.15M864K932K
Dividends Paid
000000000
Share Repurchases
000000000
Other Financing
71K-78K-1.84M93.91M-374K-1.87M-1.52M-1.56M-3.49M
Net Change in Cash
-6.07M▲ 0%
10.84M▲ 278.5%
141.31M▲ 1203.5%
64.91M▼ 54.1%
-35.54M▼ 154.8%
-67.38M▼ 89.6%
-77.01M▼ 14.3%
26.39M▲ 134.3%
-11.71M▲ 0%
Free Cash Flow
-9.63M▲ 0%
-11.4M▼ 18.4%
4.12M▲ 136.2%
-29.82M▼ 823.4%
-22.98M▲ 23.0%
-27.1M▼ 18.0%
-30.85M▼ 13.8%
-24.64M▲ 20.1%
-8.42M▲ 0%
FCF Margin %
-43.64%-63.41%15.33%-70.65%-49.04%-53.96%-51.73%-43.85%-14.57%
FCF Growth %
--18.4%136.17%-823.41%22.95%-17.97%-13.82%20.12%76.46%
FCF per Share
-1.19-1.510.75-1.07-0.73-0.84-0.91-0.63-0.23
FCF Conversion (FCF/Net Income)
1.18x0.82x-0.32x1.31x0.62x0.69x0.42x0.65x0.23x
Interest Paid
01.16M913K0135K0184K00
Taxes Paid
000000000

MASS Key Ratios

908 Devices Inc. (MASS) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025TTM
Return on Equity (ROE)
--33.79%-12.54%-16.57%-20.44%-51.56%-28.37%-25.5%
Return on Invested Capital (ROIC)
---253.57%-160.5%-88.98%-90.21%-29.11%-28.61%
Gross Margin
45.31%55.49%55.05%55.54%50.41%50.18%47.68%49%
Net Margin
-74.41%-47.66%-52.53%-71.64%-72.47%-121.09%-65.2%-62.1%
Debt / Equity
-0.16x0.10x0.10x0.04x0.06x0.12x0.03x
Interest Coverage
-7.94x-5.96x-44.62x-259.18x-212.19x---
FCF Conversion
0.82x-0.32x1.31x0.62x0.69x0.42x0.65x0.23x
Revenue Growth
-18.51%49.64%56.93%11.01%7.21%18.72%-5.76%2.16%
Related:MASS Dividend History·MASS Revenue History·MASS Price History·MASS P/E History·MASS Financial Ratios·MASS Institutional Holders

MASS SEC Filings & Documents

908 Devices Inc. (MASS) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Mar 3, 2026·SEC

Material company update

Jan 20, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 9, 2026·SEC

FY 2025

Mar 7, 2025·SEC

FY 2024

Mar 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Nov 10, 2025·SEC

FY 2025

Aug 5, 2025·SEC

MASS Frequently Asked Questions

908 Devices Inc. (MASS) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

908 Devices Inc. (MASS) reported $57.8M in revenue for fiscal year 2025. This represents a 162% increase from $22.1M in 2018.

908 Devices Inc. (MASS) saw revenue decline by 5.8% over the past year.

908 Devices Inc. (MASS) reported a net loss of $35.9M for fiscal year 2025.

Dividend & Returns

908 Devices Inc. (MASS) has a return on equity (ROE) of -28.4%. Negative ROE indicates the company is unprofitable.

908 Devices Inc. (MASS) had negative free cash flow of $8.4M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in MASS back in 2018?

Total return calculator · dividends reinvested · 8+ years of data

See returns →

How much would $100/month in MASS be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →